Predicting treatment response in common blood cancer with DN

A recent study led by Dr. Manel Esteller, Director of the Josep Carreras Institute, shows how DNA methylation profiling in a common type of blood cancer, myelodysplastic syndrome, predicts whether the patient will respond to treatment.

Related Keywords

United Kingdom , Barcelona , Comunidad Autonoma De Cataluna , Spain , British , Blanca Xicoy , Manel Esteller , Lurdes Zamora , Francesc Sol , Research Professor , Josep Carreras Leukaemia Research Institute , Josep Carreras Institute , University Of Bologna , Carreras Leukaemia Research , British Journal , Hebron Hospital ,